Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer
Simona D’Aguanno, Donatella Del Bufalo
Cells (2020) Vol. 9, Iss. 5, pp. 1287-1287
Open Access | Times Cited: 122

Showing 1-25 of 122 citing articles:

Targeting MCL-1 in cancer: current status and perspectives
Haolan Wang, Ming Guo, Hudie Wei, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 231
Recent Advances in Oligonucleotide Therapeutics in Oncology
Haoyu Xiong, Rakesh N. Veedu, Sarah D. Diermeier
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3295-3295
Open Access | Times Cited: 148
The interplay between apoptosis and cellular senescence: Bcl-2 family proteins as targets for cancer therapy
Alakananda Basu
Pharmacology & Therapeutics (2021) Vol. 230, pp. 107943-107943
Closed Access | Times Cited: 125
Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance
Adnin Ashrafi, Zakia Akter, Pouya Modareszadeh, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4562-4562
Open Access | Times Cited: 70
Emerging biomarkers and potential therapeutics of the BCL-2 protein family: the apoptotic and anti-apoptotic context
Md. Saddam, Shamrat Kumar Paul, Mohammad Ahsan Habib, et al.
Egyptian Journal of Medical Human Genetics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 19
Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing
Megan Stevens, Sebastian Oltean
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 113
B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy
Manzar Alam, Sabeeha Ali, Taj Mohammad, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10442-10442
Open Access | Times Cited: 68
The role of selected non-coding RNAs in the biology of non-small cell lung cancer
Kajetan Kiełbowski, Konrad Ptaszyński, Janusz Wójcik, et al.
Advances in Medical Sciences (2023) Vol. 68, Iss. 1, pp. 121-137
Open Access | Times Cited: 26
Folic Acid Functionalized Diallyl Trisulfide–Solid Lipid Nanoparticles for Targeting Triple Negative Breast Cancer
Anindita De, Parikshit Roychowdhury, Nihar Ranjan Bhuyan, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1393-1393
Open Access | Times Cited: 23
Natural Products as Regulators against Matrix Metalloproteinases for the Treatment of Cancer
Md. Towhedul Islam, Nak Han Jang, Hyuck Jin Lee
Biomedicines (2024) Vol. 12, Iss. 4, pp. 794-794
Open Access | Times Cited: 14
Design, synthesis, and characterization of M(II)-Schiff base complexes containing 3,5-di-tert-butyl salicylaldehyde: DNA binding/cleavage, DPPH radical scavenging activity, cytotoxic activity, and catalytic activity investigation
Himadri Priya Gogoi, Akalesh K. Verma, Munmi Gogoi, et al.
Inorganic Chemistry Communications (2024) Vol. 165, pp. 112462-112462
Closed Access | Times Cited: 8
The Potential Role of Sanguinarine as an Inhibitor of Leishmania PP2C in the Induction of Apoptosis
M. Ornelas-Cruces, Alma Reyna Escalona‐Montaño, Norma Salaiza‐Suazo, et al.
Acta Parasitologica (2025) Vol. 70, Iss. 1
Open Access | Times Cited: 1
Exploring the anticancer potential of Hewittia malabarica through phytochemical analysis and molecular docking study
Shiji Thozhukkad Moosaripparambil, Kannan Vadakkadath Meethal
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Exosomes-coated bcl-2 siRNA inhibits the growth of digestive system tumors both in vitro and in vivo
Hongyu Tao, Huanli Xu, Ling Zuo, et al.
International Journal of Biological Macromolecules (2020) Vol. 161, pp. 470-480
Closed Access | Times Cited: 51
Nano-Based Targeted Drug Delivery for Lung Cancer: Therapeutic Avenues and Challenges
Devaraj Ezhilarasan, Lakshmi Thangavelu, Sreekanth Kumar Mallineni
Nanomedicine (2022) Vol. 17, Iss. 24, pp. 1855-1869
Closed Access | Times Cited: 35
Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer
Yannan Zheng, Wenhui Zhang, Lin Xu, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 28
Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications
Ishita Gupta, Ola Hussein, Konduru S. Sastry, et al.
Advances in Cancer Biology - Metastasis (2023) Vol. 8, pp. 100107-100107
Open Access | Times Cited: 19
Mitochondrial signaling pathways and their role in cancer drug resistance
Ashwani Sharma, Tarun Virmani, Girish Kumar, et al.
Cellular Signalling (2024) Vol. 122, pp. 111329-111329
Closed Access | Times Cited: 7
Enantiomeric alkynyl-protected Au10 clusters with chirality-dependent radiotherapy enhancing effects
Tongtong Jia, Bingjie Li, Guang Yang, et al.
Nano Today (2021) Vol. 39, pp. 101222-101222
Closed Access | Times Cited: 38
Modulation of Ca2+ signaling by antiapoptotic Bcl-2 versus Bcl-xL: From molecular mechanisms to relevance for cancer cell survival
Nicolas Rosa, Femke Speelman-Rooms, Jan B. Parys, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 6, pp. 188791-188791
Open Access | Times Cited: 26
Silver nanoparticles induce mitochondria-dependent apoptosis and late non-canonical autophagy in HT-29 colon cancer cells
Jun Bao, Ziyu Jiang, Wenlong Ding, et al.
Nanotechnology Reviews (2022) Vol. 11, Iss. 1, pp. 1911-1926
Open Access | Times Cited: 22
Bcl-2 family inhibitors sensitize human cancer models to therapy
Elisabetta Valentini, Marta Di Martile, Matteo Brignone, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 14
Lipocalin-2: A Nurturer of Tumor Progression and a Novel Candidate for Targeted Cancer Therapy
Maida Živalj, Jo A. Van Ginderachter, Benoı̂t Stijlemans
Cancers (2023) Vol. 15, Iss. 21, pp. 5159-5159
Open Access | Times Cited: 13
Recent Trends in Nanocarrier-Based Drug Delivery System for Prostate Cancer
Amit Kumar, Akshay Kumar Lunawat, Ashutosh Kumar, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 3
Closed Access | Times Cited: 5
Biological Evaluation of Novel 5-((1H-indol-3-yl) methyl)-2-(4-chlorobenzyl)-6-phenyl-imidazo[2,1-b][13,4]thiadiazole Derivatives as Novel BCL-2 Specific Inhibitors
S. Chidananda Sharma, Sadashivamurthy Shamanth, Humaira Siddiqua, et al.
European Journal of Medicinal Chemistry Reports (2025) Vol. 13, pp. 100247-100247
Closed Access
Page 1 - Next Page

Scroll to top